While most reports point to the association of high levels of iNOS expression in ovarian tumors with the risk of disease relapse and patient death, some reports indicate that ovarian tumor cells with high iNOS expression are more sensitive to cisplatin treatment. This evidence concerns the gene NOS2 and ovarian neoplasm.